

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06561164 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 3.57660166 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43218150 |
| 4 | cell adhesion mediated by integrin (GO:0033627) | 3.42058215 |
| 5 | negative regulation of interleukin-12 production (GO:0032695) | 3.40733476 |
| 6 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.27055304 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24332830 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 3.24332830 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24332830 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24332830 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24332830 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.24332830 |
| 13 | regulation of cholesterol storage (GO:0010885) | 3.21668583 |
| 14 | protein localization to endosome (GO:0036010) | 3.18683154 |
| 15 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13730060 |
| 16 | membrane raft organization (GO:0031579) | 3.11300618 |
| 17 | hypotonic response (GO:0006971) | 3.09125938 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06247859 |
| 19 | apoptotic cell clearance (GO:0043277) | 2.98527041 |
| 20 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.98119754 |
| 21 | positive regulation of p38MAPK cascade (GO:1900745) | 2.94095313 |
| 22 | growth hormone receptor signaling pathway (GO:0060396) | 2.89990584 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89587003 |
| 24 | complement activation, alternative pathway (GO:0006957) | 2.89569956 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88669370 |
| 26 | negative regulation of cell killing (GO:0031342) | 2.88669370 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 2.87706809 |
| 28 | plasma lipoprotein particle clearance (GO:0034381) | 2.84702003 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84107832 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84107832 |
| 31 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83453112 |
| 32 | fibril organization (GO:0097435) | 2.82300324 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82046949 |
| 34 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.81062192 |
| 35 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.80298001 |
| 36 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78798555 |
| 37 | detection of external biotic stimulus (GO:0098581) | 2.78441970 |
| 38 | cardiac myofibril assembly (GO:0055003) | 2.78344839 |
| 39 | positive regulation of lipid storage (GO:0010884) | 2.78068205 |
| 40 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.76088703 |
| 41 | detection of other organism (GO:0098543) | 2.75647398 |
| 42 | regulation of sequestering of triglyceride (GO:0010889) | 2.74957578 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 2.73412745 |
| 44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.73053015 |
| 45 | response to host defenses (GO:0052200) | 2.71261628 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71261628 |
| 47 | response to host (GO:0075136) | 2.71261628 |
| 48 | regulation of complement activation (GO:0030449) | 2.69312337 |
| 49 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.68293844 |
| 50 | regulation of protein activation cascade (GO:2000257) | 2.68136663 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.67626237 |
| 52 | endodermal cell differentiation (GO:0035987) | 2.67136592 |
| 53 | fatty acid transmembrane transport (GO:1902001) | 2.65043702 |
| 54 | cellular response to type I interferon (GO:0071357) | 2.64320229 |
| 55 | type I interferon signaling pathway (GO:0060337) | 2.64320229 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 2.62846843 |
| 57 | response to type I interferon (GO:0034340) | 2.61965535 |
| 58 | regulation of interferon-alpha production (GO:0032647) | 2.61252378 |
| 59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.60906194 |
| 60 | protein carboxylation (GO:0018214) | 2.60906194 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 2.58394285 |
| 62 | barbed-end actin filament capping (GO:0051016) | 2.57591661 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 2.56538112 |
| 64 | positive regulation of hemostasis (GO:1900048) | 2.56538112 |
| 65 | germinal center formation (GO:0002467) | 2.56399697 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.56398460 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 2.55642015 |
| 68 | T-helper 1 type immune response (GO:0042088) | 2.54636541 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 2.52546793 |
| 70 | negative regulation of interleukin-17 production (GO:0032700) | 2.52540549 |
| 71 | granulocyte activation (GO:0036230) | 2.51384176 |
| 72 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.51337191 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.49381033 |
| 74 | positive regulation of type 2 immune response (GO:0002830) | 2.48818967 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.48393386 |
| 76 | sarcomere organization (GO:0045214) | 2.48265500 |
| 77 | negative regulation of lipid storage (GO:0010888) | 2.47422824 |
| 78 | regulation of type 2 immune response (GO:0002828) | 2.47420609 |
| 79 | cellular response to growth hormone stimulus (GO:0071378) | 2.47016553 |
| 80 | extracellular fibril organization (GO:0043206) | 2.46478219 |
| 81 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.45821200 |
| 82 | substrate-dependent cell migration (GO:0006929) | 2.45675561 |
| 83 | positive regulation of coagulation (GO:0050820) | 2.45436977 |
| 84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.44818328 |
| 85 | negative regulation of monooxygenase activity (GO:0032769) | 2.44393001 |
| 86 | regulation of macrophage cytokine production (GO:0010935) | 2.43689457 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.43258434 |
| 88 | collagen fibril organization (GO:0030199) | 2.42795596 |
| 89 | neutrophil activation (GO:0042119) | 2.42425523 |
| 90 | detection of biotic stimulus (GO:0009595) | 2.40653931 |
| 91 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.40000368 |
| 92 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.39788734 |
| 93 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.39099390 |
| 94 | phospholipid homeostasis (GO:0055091) | 2.39050430 |
| 95 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.38975393 |
| 96 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.38873703 |
| 97 | positive regulation of tolerance induction (GO:0002645) | 2.38586469 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38228934 |
| 99 | regulation of monocyte chemotaxis (GO:0090025) | 2.38090728 |
| 100 | regulation of necroptotic process (GO:0060544) | 2.37725195 |
| 101 | response to peptidoglycan (GO:0032494) | 2.37330136 |
| 102 | positive regulation of macrophage cytokine production (GO:0060907) | 2.37314532 |
| 103 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.36925847 |
| 104 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.36741588 |
| 105 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.36739259 |
| 106 | cellular extravasation (GO:0045123) | 2.36689121 |
| 107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.34619440 |
| 108 | pinocytosis (GO:0006907) | 2.34404447 |
| 109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.33955656 |
| 110 | skin morphogenesis (GO:0043589) | 2.33954338 |
| 111 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.33905205 |
| 112 | detection of bacterium (GO:0016045) | 2.32315345 |
| 113 | positive regulation of fatty acid oxidation (GO:0046321) | 2.32094949 |
| 114 | stress fiber assembly (GO:0043149) | 2.31019483 |
| 115 | basement membrane organization (GO:0071711) | 2.30184927 |
| 116 | macrophage activation (GO:0042116) | 2.30041775 |
| 117 | positive regulation of interleukin-6 production (GO:0032755) | 2.30035619 |
| 118 | regulation of vitamin metabolic process (GO:0030656) | 2.29938202 |
| 119 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.29535608 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.29013384 |
| 121 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.29013384 |
| 122 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.28701056 |
| 123 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.27228524 |
| 124 | regulation of fibrinolysis (GO:0051917) | 2.27169954 |
| 125 | myofibril assembly (GO:0030239) | 2.26647470 |
| 126 | carnitine shuttle (GO:0006853) | 2.25198192 |
| 127 | regulation of triglyceride catabolic process (GO:0010896) | 2.25088569 |
| 128 | negative regulation of type 2 immune response (GO:0002829) | 2.24986368 |
| 129 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.24944877 |
| 130 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.24942050 |
| 131 | positive regulation of extracellular matrix organization (GO:1903055) | 2.24256406 |
| 132 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.24140331 |
| 133 | 2-oxoglutarate metabolic process (GO:0006103) | 2.24130454 |
| 134 | mesodermal cell differentiation (GO:0048333) | 2.24025162 |
| 135 | defense response to protozoan (GO:0042832) | 2.23277860 |
| 136 | positive regulation of receptor recycling (GO:0001921) | 2.22389853 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 2.21445851 |
| 138 | regulation of mononuclear cell migration (GO:0071675) | 2.21309061 |
| 139 | lymphocyte chemotaxis (GO:0048247) | 2.21090276 |
| 140 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.20810537 |
| 141 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.19126885 |
| 142 | fibrinolysis (GO:0042730) | 2.18633559 |
| 143 | fibroblast migration (GO:0010761) | 2.18599230 |
| 144 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.18424054 |
| 145 | regulation of lipid storage (GO:0010883) | 2.18403905 |
| 146 | immunoglobulin mediated immune response (GO:0016064) | 2.18067207 |
| 147 | collagen metabolic process (GO:0032963) | 2.18051992 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 2.17670019 |
| 149 | regulation of p38MAPK cascade (GO:1900744) | 2.16075628 |
| 150 | valine metabolic process (GO:0006573) | 2.15975753 |
| 151 | response to muramyl dipeptide (GO:0032495) | 2.15018584 |
| 152 | negative regulation of fatty acid transport (GO:2000192) | 2.13825127 |
| 153 | negative regulation of granulocyte differentiation (GO:0030853) | 2.13021106 |
| 154 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.12950563 |
| 155 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.12910292 |
| 156 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.12295932 |
| 157 | alpha-linolenic acid metabolic process (GO:0036109) | 2.10952505 |
| 158 | response to host immune response (GO:0052572) | 2.10468896 |
| 159 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.10468896 |
| 160 | regulation of macrophage chemotaxis (GO:0010758) | 2.10179137 |
| 161 | regulation of fatty acid oxidation (GO:0046320) | 2.09606579 |
| 162 | collagen catabolic process (GO:0030574) | 2.09219205 |
| 163 | response to fluid shear stress (GO:0034405) | 2.08533597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.02145793 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81928054 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71156312 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.27231929 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12840885 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99967389 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97916543 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86677606 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.76922358 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.73141494 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.72903026 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.69436976 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64248789 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.61267754 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60580809 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54170033 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47502860 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45369931 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.42043371 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36198449 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.35942745 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28081354 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27954340 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.18376879 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17958207 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.04724590 |
| 27 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.98992907 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.98626397 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91232317 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87085334 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.81207688 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81118553 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78797485 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74916787 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73450090 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69879709 |
| 37 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.63200884 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.63048520 |
| 39 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62561321 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57652804 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56127862 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54703075 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52530073 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51955652 |
| 45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.49690523 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.49690523 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49460040 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48962974 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.47693020 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47212877 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46885727 |
| 52 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44819992 |
| 53 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44171973 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41967624 |
| 55 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39346096 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39322851 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37651469 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37651469 |
| 59 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37595267 |
| 60 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37595267 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37508284 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33804544 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33210955 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31499258 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30024802 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28006136 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23549738 |
| 68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22330238 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22044274 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21693297 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21195407 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.21002561 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20141271 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19694086 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19681915 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19259563 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18505551 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16535030 |
| 79 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15524480 |
| 80 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14792200 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14684919 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14502695 |
| 83 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13402924 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12937146 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12796407 |
| 86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12475090 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11826414 |
| 88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10815369 |
| 89 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10584143 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.09332558 |
| 91 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09301385 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08861292 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08711155 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08608497 |
| 95 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07731624 |
| 96 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.07630852 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04074421 |
| 98 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03355752 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01879399 |
| 100 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01835767 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00528205 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99877125 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97410399 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96704158 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96107451 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 0.94209675 |
| 107 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94165475 |
| 108 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94088403 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92812973 |
| 110 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91851143 |
| 111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91687611 |
| 112 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91613672 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90522638 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90439937 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90376246 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90254188 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90066372 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89940957 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88520337 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87798844 |
| 121 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85979617 |
| 122 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.85645572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.32765655 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 2.88372304 |
| 3 | MP0005275_abnormal_skin_tensile | 2.55006365 |
| 4 | MP0003279_aneurysm | 2.28383245 |
| 5 | MP0003436_decreased_susceptibility_to | 2.21117850 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.15177644 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.14888247 |
| 8 | MP0004510_myositis | 2.13931086 |
| 9 | MP0003300_gastrointestinal_ulcer | 1.92054450 |
| 10 | MP0000343_altered_response_to | 1.91914648 |
| 11 | MP0010368_abnormal_lymphatic_system | 1.91853844 |
| 12 | MP0003303_peritoneal_inflammation | 1.91350768 |
| 13 | MP0001835_abnormal_antigen_presentation | 1.86221570 |
| 14 | MP0002254_reproductive_system_inflammat | 1.85236016 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.79127098 |
| 16 | MP0003828_pulmonary_edema | 1.77707587 |
| 17 | MP0005503_abnormal_tendon_morphology | 1.73769055 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.73752368 |
| 19 | MP0005360_urolithiasis | 1.72439369 |
| 20 | MP0001542_abnormal_bone_strength | 1.68739253 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.62989301 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.59383431 |
| 23 | MP0005451_abnormal_body_composition | 1.58323232 |
| 24 | MP0009840_abnormal_foam_cell | 1.56969510 |
| 25 | MP0002419_abnormal_innate_immunity | 1.56117162 |
| 26 | MP0008004_abnormal_stomach_pH | 1.56043294 |
| 27 | MP0001958_emphysema | 1.54522908 |
| 28 | MP0004130_abnormal_muscle_cell | 1.53264751 |
| 29 | MP0004883_abnormal_blood_vessel | 1.52272621 |
| 30 | MP0000685_abnormal_immune_system | 1.51396586 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.51054078 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.49828538 |
| 33 | MP0003724_increased_susceptibility_to | 1.48959726 |
| 34 | MP0006054_spinal_hemorrhage | 1.47411374 |
| 35 | * MP0009785_altered_susceptibility_to | 1.44779147 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.44575433 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.43382822 |
| 38 | MP0000767_abnormal_smooth_muscle | 1.43136382 |
| 39 | MP0005365_abnormal_bile_salt | 1.40580795 |
| 40 | MP0003075_altered_response_to | 1.38250689 |
| 41 | MP0003252_abnormal_bile_duct | 1.37060044 |
| 42 | MP0004272_abnormal_basement_membrane | 1.36491159 |
| 43 | MP0005023_abnormal_wound_healing | 1.33535534 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.33267277 |
| 45 | MP0000751_myopathy | 1.32527046 |
| 46 | MP0001879_abnormal_lymphatic_vessel | 1.31802025 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.31677308 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.29185638 |
| 49 | MP0006082_CNS_inflammation | 1.28567515 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.27997286 |
| 51 | MP0001790_abnormal_immune_system | 1.27820871 |
| 52 | MP0005387_immune_system_phenotype | 1.27820871 |
| 53 | MP0009278_abnormal_bone_marrow | 1.26548714 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.24184428 |
| 55 | MP0009764_decreased_sensitivity_to | 1.23953228 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.23808582 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.22873741 |
| 58 | MP0005330_cardiomyopathy | 1.21924265 |
| 59 | MP0002972_abnormal_cardiac_muscle | 1.21919005 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.21504381 |
| 61 | MP0002933_joint_inflammation | 1.21408568 |
| 62 | MP0003448_altered_tumor_morphology | 1.20408098 |
| 63 | MP0008775_abnormal_heart_ventricle | 1.20301402 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.20269128 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.20017955 |
| 66 | MP0005165_increased_susceptibility_to | 1.18305757 |
| 67 | MP0001544_abnormal_cardiovascular_syste | 1.17492348 |
| 68 | MP0005385_cardiovascular_system_phenoty | 1.17492348 |
| 69 | * MP0005025_abnormal_response_to | 1.16526368 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.16288063 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.16001968 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.15549530 |
| 73 | MP0003045_fibrosis | 1.15446172 |
| 74 | MP0005671_abnormal_response_to | 1.14823880 |
| 75 | MP0003091_abnormal_cell_migration | 1.14480605 |
| 76 | MP0002060_abnormal_skin_morphology | 1.13878483 |
| 77 | MP0005595_abnormal_vascular_smooth | 1.13163457 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.12811246 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.12548185 |
| 80 | MP0002452_abnormal_antigen_presenting | 1.10621071 |
| 81 | MP0005166_decreased_susceptibility_to | 1.10612898 |
| 82 | MP0003763_abnormal_thymus_physiology | 1.10395426 |
| 83 | MP0001853_heart_inflammation | 1.09808233 |
| 84 | MP0008260_abnormal_autophagy | 1.09250270 |
| 85 | MP0002006_tumorigenesis | 1.08285166 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 1.07471741 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 1.06592837 |
| 88 | MP0004947_skin_inflammation | 1.06504438 |
| 89 | MP0000858_altered_metastatic_potential | 1.04642037 |
| 90 | MP0000609_abnormal_liver_physiology | 1.04062991 |
| 91 | MP0001800_abnormal_humoral_immune | 1.02996599 |
| 92 | MP0004215_abnormal_myocardial_fiber | 1.01509386 |
| 93 | MP0000249_abnormal_blood_vessel | 1.00474674 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00144816 |
| 95 | MP0008469_abnormal_protein_level | 0.99423549 |
| 96 | MP0000733_abnormal_muscle_development | 0.99204175 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.98583976 |
| 98 | MP0001851_eye_inflammation | 0.97763598 |
| 99 | MP0002896_abnormal_bone_mineralization | 0.96952408 |
| 100 | MP0002405_respiratory_system_inflammati | 0.95769137 |
| 101 | MP0005390_skeleton_phenotype | 0.94094546 |
| 102 | MP0005164_abnormal_response_to | 0.92613077 |
| 103 | MP0002723_abnormal_immune_serum | 0.91515516 |
| 104 | MP0000749_muscle_degeneration | 0.90037616 |
| 105 | MP0003795_abnormal_bone_structure | 0.89363615 |
| 106 | MP0000716_abnormal_immune_system | 0.89181181 |
| 107 | MP0000604_amyloidosis | 0.88974942 |
| 108 | MP0006138_congestive_heart_failure | 0.88746003 |
| 109 | MP0009763_increased_sensitivity_to | 0.88435413 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.87824790 |
| 111 | MP0002128_abnormal_blood_circulation | 0.86787581 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.86123251 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.85806318 |
| 114 | MP0001243_abnormal_dermal_layer | 0.85138712 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.84529339 |
| 116 | MP0005409_darkened_coat_color | 0.84387669 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.84331621 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.83901335 |
| 119 | MP0001819_abnormal_immune_cell | 0.83307011 |
| 120 | MP0002420_abnormal_adaptive_immunity | 0.82556339 |
| 121 | MP0005397_hematopoietic_system_phenotyp | 0.82528289 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.82528289 |
| 123 | MP0002398_abnormal_bone_marrow | 0.82069259 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.82000267 |
| 125 | MP0005257_abnormal_intraocular_pressure | 0.79950164 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.78280981 |
| 127 | MP0002168_other_aberrant_phenotype | 0.74562408 |
| 128 | MP0001915_intracranial_hemorrhage | 0.72386856 |
| 129 | MP0009333_abnormal_splenocyte_physiolog | 0.71663918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.65653657 |
| 2 | Premature rupture of membranes (HP:0001788) | 3.61463688 |
| 3 | Myocardial infarction (HP:0001658) | 3.58106978 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 3.41847277 |
| 5 | Complement deficiency (HP:0004431) | 3.32970886 |
| 6 | Aortic dissection (HP:0002647) | 3.25611315 |
| 7 | Aortic aneurysm (HP:0004942) | 3.16005542 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15980813 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15980813 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15980813 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.14998935 |
| 12 | Peritonitis (HP:0002586) | 3.12159565 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.11980087 |
| 14 | Increased connective tissue (HP:0009025) | 3.11522729 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09476078 |
| 16 | Osteolytic defects of the hand bones (HP:0009699) | 3.01804868 |
| 17 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.01804868 |
| 18 | Hematochezia (HP:0002573) | 3.01174034 |
| 19 | Ankle contracture (HP:0006466) | 2.98418397 |
| 20 | Cerebral aneurysm (HP:0004944) | 2.97481122 |
| 21 | Ventricular tachycardia (HP:0004756) | 2.94656395 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 2.92014789 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.87654571 |
| 24 | Abnormality of complement system (HP:0005339) | 2.87423060 |
| 25 | Amyloidosis (HP:0011034) | 2.81604311 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.80583079 |
| 27 | Broad metatarsal (HP:0001783) | 2.66913519 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.65572897 |
| 29 | Lipoatrophy (HP:0100578) | 2.64037253 |
| 30 | Myositis (HP:0100614) | 2.61742351 |
| 31 | Vertebral compression fractures (HP:0002953) | 2.60646794 |
| 32 | Xanthomatosis (HP:0000991) | 2.53721322 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 2.52983435 |
| 34 | Sudden death (HP:0001699) | 2.50069264 |
| 35 | Orchitis (HP:0100796) | 2.43288598 |
| 36 | Glomerulonephritis (HP:0000099) | 2.42113313 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.41746471 |
| 38 | Esophageal varix (HP:0002040) | 2.40944115 |
| 39 | Mitral valve prolapse (HP:0001634) | 2.39034770 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.36719357 |
| 41 | Exercise-induced muscle cramps (HP:0003710) | 2.34736685 |
| 42 | Cervical subluxation (HP:0003308) | 2.28607391 |
| 43 | Nephritis (HP:0000123) | 2.27682250 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27060734 |
| 45 | Aortic regurgitation (HP:0001659) | 2.25073509 |
| 46 | Arterial thrombosis (HP:0004420) | 2.23430218 |
| 47 | Mitral stenosis (HP:0001718) | 2.22769245 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.21437166 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21437166 |
| 50 | Stomatitis (HP:0010280) | 2.20051693 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.19782178 |
| 52 | Dilatation of the ascending aorta (HP:0005111) | 2.19255557 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18775107 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18775107 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18775107 |
| 56 | Epistaxis (HP:0000421) | 2.17985395 |
| 57 | Soft skin (HP:0000977) | 2.17427540 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.16817297 |
| 59 | Aneurysm (HP:0002617) | 2.16787192 |
| 60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16042190 |
| 61 | Arterial tortuosity (HP:0005116) | 2.15440117 |
| 62 | Atrial fibrillation (HP:0005110) | 2.14736231 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.13929592 |
| 64 | Muscle fiber splitting (HP:0003555) | 2.13272491 |
| 65 | Tetraparesis (HP:0002273) | 2.12472667 |
| 66 | Hyporeflexia of lower limbs (HP:0002600) | 2.11548943 |
| 67 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.10913345 |
| 68 | Vascular tortuosity (HP:0004948) | 2.09978863 |
| 69 | Joint hemorrhage (HP:0005261) | 2.08845492 |
| 70 | Thoracolumbar scoliosis (HP:0002944) | 2.08649142 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.07479755 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.07479755 |
| 73 | Axonal loss (HP:0003447) | 2.07146141 |
| 74 | Spondylolisthesis (HP:0003302) | 2.06782835 |
| 75 | Increased density of long bones (HP:0006392) | 2.06155490 |
| 76 | Striae distensae (HP:0001065) | 2.04129820 |
| 77 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99068351 |
| 78 | Blue sclerae (HP:0000592) | 1.97512026 |
| 79 | Lymphangioma (HP:0100764) | 1.96868319 |
| 80 | T lymphocytopenia (HP:0005403) | 1.96587635 |
| 81 | Atrophic scars (HP:0001075) | 1.96263154 |
| 82 | Mediastinal lymphadenopathy (HP:0100721) | 1.95851118 |
| 83 | Keratoconjunctivitis (HP:0001096) | 1.95046534 |
| 84 | Impaired platelet aggregation (HP:0003540) | 1.94776627 |
| 85 | Abnormal platelet function (HP:0011869) | 1.94776627 |
| 86 | Joint stiffness (HP:0001387) | 1.94171698 |
| 87 | Primary atrial arrhythmia (HP:0001692) | 1.93901002 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 1.93429586 |
| 89 | Fragile skin (HP:0001030) | 1.92412964 |
| 90 | Conjunctival telangiectasia (HP:0000524) | 1.92326644 |
| 91 | Hemoptysis (HP:0002105) | 1.91318689 |
| 92 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.91049461 |
| 93 | Subaortic stenosis (HP:0001682) | 1.91049461 |
| 94 | Abnormality of macrophages (HP:0004311) | 1.89844491 |
| 95 | Gingival bleeding (HP:0000225) | 1.89121902 |
| 96 | Thick nail (HP:0001805) | 1.88702423 |
| 97 | Abnormality of T cell number (HP:0011839) | 1.87479874 |
| 98 | Absent frontal sinuses (HP:0002688) | 1.87209489 |
| 99 | Prolonged bleeding time (HP:0003010) | 1.87153990 |
| 100 | Optic neuritis (HP:0100653) | 1.86795865 |
| 101 | Retrobulbar optic neuritis (HP:0100654) | 1.86795865 |
| 102 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85952360 |
| 103 | Spinal rigidity (HP:0003306) | 1.85804676 |
| 104 | Chest pain (HP:0100749) | 1.84995975 |
| 105 | Increased mean platelet volume (HP:0011877) | 1.84964305 |
| 106 | Gingivitis (HP:0000230) | 1.84891578 |
| 107 | Cellulitis (HP:0100658) | 1.84787448 |
| 108 | Recurrent skin infections (HP:0001581) | 1.84728978 |
| 109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83814517 |
| 110 | Vasculitis (HP:0002633) | 1.83248911 |
| 111 | Interstitial pulmonary disease (HP:0006530) | 1.82984936 |
| 112 | Supraventricular arrhythmia (HP:0005115) | 1.82913678 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 1.82454548 |
| 114 | Wormian bones (HP:0002645) | 1.82399096 |
| 115 | Abnormal platelet volume (HP:0011876) | 1.82129228 |
| 116 | Thin bony cortex (HP:0002753) | 1.81133971 |
| 117 | Supraventricular tachycardia (HP:0004755) | 1.80533534 |
| 118 | Hypoglycemic coma (HP:0001325) | 1.80158611 |
| 119 | Recurrent fungal infections (HP:0002841) | 1.79687432 |
| 120 | Polycythemia (HP:0001901) | 1.79646844 |
| 121 | Mucosal telangiectasiae (HP:0100579) | 1.79241175 |
| 122 | Ovoid vertebral bodies (HP:0003300) | 1.79220489 |
| 123 | Syringomyelia (HP:0003396) | 1.79128986 |
| 124 | Spinal cord lesions (HP:0100561) | 1.79128986 |
| 125 | Abnormality of the pericardium (HP:0001697) | 1.78928376 |
| 126 | Dilated cardiomyopathy (HP:0001644) | 1.78693291 |
| 127 | Pulmonary embolism (HP:0002204) | 1.78503072 |
| 128 | Facial diplegia (HP:0001349) | 1.78338031 |
| 129 | Genu recurvatum (HP:0002816) | 1.77693033 |
| 130 | Nonimmune hydrops fetalis (HP:0001790) | 1.77542841 |
| 131 | Autoimmune hemolytic anemia (HP:0001890) | 1.77441192 |
| 132 | Joint laxity (HP:0001388) | 1.76420778 |
| 133 | Persistence of primary teeth (HP:0006335) | 1.75902191 |
| 134 | Increased cerebral lipofuscin (HP:0011813) | 1.75634485 |
| 135 | Bruising susceptibility (HP:0000978) | 1.75380058 |
| 136 | Abnormality of skull ossification (HP:0002703) | 1.74800741 |
| 137 | Follicular hyperkeratosis (HP:0007502) | 1.73227860 |
| 138 | Hypolipoproteinemia (HP:0010981) | 1.73198582 |
| 139 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.73069133 |
| 140 | Distal lower limb amyotrophy (HP:0008944) | 1.73002388 |
| 141 | Shallow orbits (HP:0000586) | 1.72826387 |
| 142 | Keratoconjunctivitis sicca (HP:0001097) | 1.71396275 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.71191000 |
| 144 | Hypercholesterolemia (HP:0003124) | 1.70860293 |
| 145 | Periodontitis (HP:0000704) | 1.70672306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.59131582 |
| 2 | TRIB3 | 3.11829849 |
| 3 | PKN2 | 3.03069507 |
| 4 | TGFBR2 | 2.76826810 |
| 5 | ERN1 | 2.50540493 |
| 6 | TBK1 | 2.26522737 |
| 7 | NEK9 | 2.23371812 |
| 8 | RIPK4 | 2.12153671 |
| 9 | TYK2 | 2.11838066 |
| 10 | MAP3K14 | 2.07175689 |
| 11 | FGFR4 | 1.96540649 |
| 12 | PRPF4B | 1.91286079 |
| 13 | LATS1 | 1.85655944 |
| 14 | JAK1 | 1.74315724 |
| 15 | KIT | 1.72690990 |
| 16 | MYLK | 1.71760393 |
| 17 | FLT3 | 1.64174336 |
| 18 | DMPK | 1.60426759 |
| 19 | SIK1 | 1.56491231 |
| 20 | JAK3 | 1.56097483 |
| 21 | RIPK1 | 1.55342735 |
| 22 | EPHB1 | 1.52904167 |
| 23 | MAP2K3 | 1.50319822 |
| 24 | STK24 | 1.49730637 |
| 25 | KDR | 1.47746860 |
| 26 | FGFR3 | 1.44616617 |
| 27 | EPHA3 | 1.44129193 |
| 28 | TRPM7 | 1.42099472 |
| 29 | PDGFRA | 1.41155369 |
| 30 | PTK6 | 1.40031597 |
| 31 | LRRK2 | 1.38994419 |
| 32 | TAOK2 | 1.36355176 |
| 33 | MAP3K6 | 1.34602800 |
| 34 | BMPR2 | 1.31527226 |
| 35 | TIE1 | 1.23973548 |
| 36 | FRK | 1.23516399 |
| 37 | IKBKB | 1.23299576 |
| 38 | STK10 | 1.21735855 |
| 39 | RPS6KA4 | 1.20147457 |
| 40 | CDC42BPA | 1.20136389 |
| 41 | MAP3K3 | 1.17489357 |
| 42 | DDR2 | 1.14485088 |
| 43 | TXK | 1.13037262 |
| 44 | STK3 | 1.12687349 |
| 45 | IKBKE | 1.12640968 |
| 46 | LMTK2 | 1.12502746 |
| 47 | IRAK3 | 1.12109715 |
| 48 | PIK3CG | 1.09900292 |
| 49 | CSK | 1.09073487 |
| 50 | TAOK3 | 1.09072551 |
| 51 | EPHB2 | 1.08748087 |
| 52 | CAMK1D | 1.07029524 |
| 53 | MAP4K1 | 1.06774144 |
| 54 | OBSCN | 1.06251900 |
| 55 | IRAK4 | 1.03741835 |
| 56 | CHUK | 1.02974415 |
| 57 | BLK | 1.00488430 |
| 58 | FES | 1.00408124 |
| 59 | AKT3 | 0.99924795 |
| 60 | PIK3CA | 0.91411752 |
| 61 | CSF1R | 0.90811574 |
| 62 | IRAK1 | 0.90034113 |
| 63 | ZAP70 | 0.89949048 |
| 64 | MAP3K10 | 0.89918719 |
| 65 | MAP3K11 | 0.89776334 |
| 66 | FGR | 0.89222028 |
| 67 | MAP3K1 | 0.88961705 |
| 68 | CLK1 | 0.88680761 |
| 69 | ITK | 0.86271065 |
| 70 | JAK2 | 0.84477885 |
| 71 | SYK | 0.84126620 |
| 72 | PRKAA2 | 0.83196351 |
| 73 | CDK6 | 0.82114487 |
| 74 | TEC | 0.79286414 |
| 75 | NUAK1 | 0.78880686 |
| 76 | PRKG2 | 0.77785458 |
| 77 | MOS | 0.77301472 |
| 78 | TGFBR1 | 0.77123131 |
| 79 | PDGFRB | 0.75128093 |
| 80 | PAK4 | 0.74000067 |
| 81 | HCK | 0.73384846 |
| 82 | GRK6 | 0.71758432 |
| 83 | PAK2 | 0.71345591 |
| 84 | MAPK7 | 0.70589790 |
| 85 | HIPK2 | 0.70445093 |
| 86 | NME2 | 0.67232463 |
| 87 | BCKDK | 0.65737514 |
| 88 | LYN | 0.65576715 |
| 89 | KSR2 | 0.65371135 |
| 90 | BMX | 0.64190218 |
| 91 | MST1R | 0.63541033 |
| 92 | TAOK1 | 0.61821615 |
| 93 | PTK2 | 0.61156867 |
| 94 | PRKD2 | 0.60614231 |
| 95 | PIM2 | 0.60547269 |
| 96 | NLK | 0.59900938 |
| 97 | STK38 | 0.59851833 |
| 98 | ILK | 0.59808958 |
| 99 | TESK1 | 0.58915095 |
| 100 | BTK | 0.57255232 |
| 101 | MAPKAPK3 | 0.56850471 |
| 102 | ABL2 | 0.56402235 |
| 103 | STK4 | 0.54531551 |
| 104 | MARK2 | 0.54525103 |
| 105 | MAP3K7 | 0.53876321 |
| 106 | TESK2 | 0.51179171 |
| 107 | RET | 0.50971736 |
| 108 | GSK3A | 0.50401682 |
| 109 | MAP3K13 | 0.49547364 |
| 110 | WNK1 | 0.49394005 |
| 111 | PRKD1 | 0.49311509 |
| 112 | MATK | 0.49048554 |
| 113 | PIM1 | 0.48965360 |
| 114 | PTK2B | 0.48235725 |
| 115 | MELK | 0.47115874 |
| 116 | EGFR | 0.47074439 |
| 117 | ABL1 | 0.46573655 |
| 118 | IRAK2 | 0.45968971 |
| 119 | PDK4 | 0.45615864 |
| 120 | PDK3 | 0.45615864 |
| 121 | LCK | 0.45602018 |
| 122 | ROCK1 | 0.45547361 |
| 123 | EPHA2 | 0.45134516 |
| 124 | YES1 | 0.44991587 |
| 125 | MAP3K2 | 0.44966820 |
| 126 | IGF1R | 0.44619875 |
| 127 | MARK3 | 0.44509438 |
| 128 | MAPK11 | 0.42480678 |
| 129 | EEF2K | 0.41849517 |
| 130 | MAPKAPK2 | 0.41674557 |
| 131 | MAPK12 | 0.41230174 |
| 132 | MAP3K5 | 0.40772916 |
| 133 | GRK7 | 0.40318173 |
| 134 | ERBB4 | 0.40278757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11517490 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48738524 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32480603 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.24159052 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.09799330 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04250937 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.85240554 |
| 8 | Malaria_Homo sapiens_hsa05144 | 1.73844983 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68179081 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67772296 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.59030992 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.58541283 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.58290373 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54574228 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.52029797 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51400497 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47534890 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46626698 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46188143 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.45855645 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41319241 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39888447 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38681595 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.35410021 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34710818 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34462603 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34371631 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.34065227 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33453727 |
| 30 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.29144063 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26475327 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.26210275 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.26072063 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25786406 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24858427 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22805623 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22316770 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22125262 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21581424 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18195922 |
| 41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.16629794 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15711045 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13960017 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.12548164 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.12204555 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.11322400 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11125913 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08412072 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 1.02607345 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99718639 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99136460 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96293623 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95066082 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94301316 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.94143229 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93692813 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92631042 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.91168900 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90605834 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.90329801 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89111026 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88400171 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.87002115 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86765689 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.86246153 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86099760 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.85769589 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.84700320 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.84279772 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82214818 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81374797 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80055483 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80044262 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79389307 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79243178 |
| 76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78785367 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78550207 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78429140 |
| 79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77113933 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75395416 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74571961 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74377407 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.74223022 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73745822 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73197773 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71984404 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71730011 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.70168940 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69933740 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68734333 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68733944 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68359069 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.67825880 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.65550098 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65279976 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64417943 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63656160 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63614098 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63399225 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.62705675 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.60641449 |
| 102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60063563 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58422545 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58341727 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56934728 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55343186 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.54825470 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54408181 |
| 109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53617671 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52884032 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52740757 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52245516 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51812700 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51508719 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51296254 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50521967 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50107975 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49944914 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49887212 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48543427 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47844064 |
| 122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47106158 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46245091 |
| 124 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46152205 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.45977953 |
| 126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45033605 |
| 127 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44960905 |
| 128 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44705986 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44629571 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44403744 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43780374 |
| 132 | Bile secretion_Homo sapiens_hsa04976 | 0.43449809 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42903291 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.42656958 |
| 135 | Hepatitis C_Homo sapiens_hsa05160 | 0.42637188 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41649392 |

